Hamburg, NJ, United States of America

Jay R Wiggins


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jay R Wiggins: Innovator in Cardiovascular Pharmaceutical Development

Introduction

Jay R Wiggins is a notable inventor based in Hamburg, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiovascular agents. His innovative work has led to the creation of novel compounds that have the potential to improve heart health.

Latest Patents

Wiggins holds a patent for "Imidazolylbenzoyl substituted heterocycles." This patent describes novel imidazolybenzoyl substituted heterocycles and their use as cardiovascular agents, especially as Class III antiarrhythmic agents. The patent also discusses pharmaceutical formulations containing such compounds, highlighting their potential therapeutic applications.

Career Highlights

Wiggins is associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceutical research and development. His work at the company has allowed him to explore innovative solutions in the cardiovascular domain, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Wiggins has collaborated with esteemed colleagues, including Yuo-Ling Chou and Paul W Erhardt. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Jay R Wiggins is a prominent figure in the pharmaceutical industry, with a focus on cardiovascular innovations. His contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…